Lithium · more major-labeled pairs than Dapagliflozin
SPL labels Dapagliflozin + Lithium as minor; Dapagliflozin 13 / Lithium 65 in that band.
Mechanism on file: Taking this diabetes medicine can cause your body to get rid of lithium faster, lowering the amount in your blood.
FDA SPL severity: Minor
Dapagliflozin + Lithium · SPL mechanism field
Taking this diabetes medicine can cause your body to get rid of lithium faster, lowering the amount in your blood.
Minor band excerpt · Dapagliflozin with Lithium
Lithium Clinical Impact Concomitant use of an SGLT2 inhibitor with lithium may decrease serum lithium concentrations. Intervention Monitor serum lithium concentration more frequently during FARXIGA initiation and dosage changes.
Dapagliflozin · 13 minor + 13 total pairs
- Bumetanide minor
- Digoxin minor
- Glimepiride minor
- Hydrochlorothiazide minor
Lithium · 2 major-labeled pairs (vs Dapagliflozin's 0)
- Aripiprazole minor
- Asenapine minor
- Canagliflozin minor
- Candesartan minor
FDA Drug Labels (SPL) via openFDA. Registry display only. Not medical advice.
Read our methodology - how this data is sourced, computed, and verified.